loadpatents
name:-0.0096631050109863
name:-0.0070838928222656
name:-0.0020339488983154
Schiedner; Gudrun Patent Filings

Schiedner; Gudrun

Patent Applications and Registrations

Patent applications and USPTO patent grants for Schiedner; Gudrun.The latest application filed is for "recombinant glycoproteins with reduced antennary fucosylation".

Company Profile
1.7.9
  • Schiedner; Gudrun - Cologne DE
  • Schiedner; Gudrun - Koln DE
  • Schiedner, Gudrun - US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Recombinant glycoproteins with reduced antennary fucosylation
Grant 11,193,156 - Schmidt , et al. December 7, 2
2021-12-07
Recombinant Glycoproteins with Reduced Antennary Fucosylation
App 20200032311 - Schmidt; Hanns-Martin ;   et al.
2020-01-30
Method for the production of permanent human cell lines
Grant 9,371,512 - Schiedner , et al. June 21, 2
2016-06-21
Method for the production of permanent human cell lines
Grant 9,315,773 - Schiedner , et al. April 19, 2
2016-04-19
Production Of A Hcmv Based Vaccine In Human Amniocyte Cell Lines
App 20150259387 - Schiedner; Gudrun ;   et al.
2015-09-17
Method For The Production Of Permanent Human Cell Lines
App 20150203813 - Schiedner; Gudrun ;   et al.
2015-07-23
Method for the production of permanent human cell lines
Grant 8,936,908 - Schiedner , et al. January 20, 2
2015-01-20
Permanent Human Cell Lines For The Production Of Influenza Viruses
App 20130344569 - Schiedner; Gudrun
2013-12-26
Novel Permanent Human Cell Line
App 20120040400 - Schiedner; Gudrun ;   et al.
2012-02-16
High capacity recombinant adenoviral vector for treatment of hemophilia A
Grant 7,238,346 - Vandendriessche , et al. July 3, 2
2007-07-03
Method for the production of permanent human cell lines
App 20070111312 - Schiedner; Gudrun ;   et al.
2007-05-17
Adenoviral vector-mediated delivery of modified steroid hormone receptors and related products and methods
App 20050196751 - Burcin, Mark M. ;   et al.
2005-09-08
High capacity recombinant adenoviral vector for treatment of hemophilia A
App 20040005293 - Vandendriessche, Thierry ;   et al.
2004-01-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed